Oezlem Tanriverdi

Oezlem Tanriverdi is a highly accomplished professional with a diverse background in both medicine and business.

She obtained her medical degree from Hacettepe University and pursued a Master of Business Administration in Business from La Salle University.

Throughout her career, Oezlem has held various key roles in reputable organizations, showcasing her expertise in program safety and clinical operations within the pharmaceutical industry.

She currently serves as the Senior Global Program Safety Lead at Novartis Oncology Early Clinical Development, highlighting her leadership in ensuring the safety of oncology programs.

Previously, Oezlem held senior positions at Novartis in the lung cancer and brand safety divisions, demonstrating her versatility and skill set.

Her experience also includes a significant role as Senior Medical Director for the Breast Cancer HER2 Franchise at Roche, further emphasizing her profound involvement in oncology.

Oezlem's past responsibilities span across drug safety, epidemiology, clinical operations, and project leadership at Novartis, underscoring her comprehensive understanding of pharmaceutical operations.

Her background as a product manager and medical advisor at Sanovel further enriches her professional portfolio, showcasing her well-rounded expertise in the industry.